Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites

NCT01349335 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Ascites
Hepatic Cirrhosis

Interventions

DRUG: Tolvaptan
DRUG: Tolvaptan
DRUG: placebo

Sponsor

Otsuka Beijing Research Institute